Published Research
Published Research
In Vivo Immune Engineering
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
September 4, 2026Dana-Farber Cancer Institute, The University of Pennsylvania, University of California, Los Angeles, University of California, San Francisco, The University of Texas MD Anderson Cancer Center
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
October 17, 2019Dana-Farber Cancer Institute